Nephrology and Hypertension

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


1635 publications

... | 2015 | 2014 | 2013 | 2012 | ...
2015
 
Eculizumab for treatment of rapidly progressive C3 glomerulopathy
Le Quintrec M., Lionet A., Kandel C., Bourdon F., Gnemmi V., Colombat M., Goujon J. M., Fremeaux-Bacchi V., Fakhouri F., 2015/03. Am J Kidney Dis, 65 (3) pp. 484-9.
[DOI][Pmid][serval:BIB_C82ABEF7B5FA]
 
L'oxalate: un déchet organique peu soluble, avec conséquences [Oxalate: a poorly soluble organic waste with consequences].
Lu Y., Bonny O., 2015/03. Praxis, 104 (7) pp. 353-359.
[DOI][Pmid][serval:BIB_E1EB3FA6C821]
Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression.
Piazzon N., Bernet F., Guihard L., Leonhard W.N., Urfer S., Firsov D., Chehade H., Vogt B., Piergiovanni S., Peters D.J. et al., 2015/03. Journal of Translational Medicine, 13 p. 103. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A10B16679B11]
 
Que peut-on attendre de la dialyse dans le futur? [What to expect from dialysis in the future?]
Schneider M., Kissling S., Saucy F., Burnier M., Pruijm M., 2015/02/25. Revue medicale suisse, 11 (463) pp. 514-516,518-520. Peer-reviewed.
[Pmid][serval:BIB_D3879D690DB8]
 
What Is the Hypertension “Phenotype”?
Michel Burnier, Grégoire Wuerzner, 2015/02/08. Current Cardiovascular Risk Reports.
[DOI][serval:BIB_133AF64A045F]
 
L'hémodiayse intermittente, irremplaçable dans certains cas d'intoxications sévères [Intermittent hemodialysis, irreplaceable in specific cases of severe poisoning].
Ventresca M., Teta D., Burnier M., Kissling S., 2015/02. Revue Médicale Suisse, 11 (463) pp. 499-504.
[Pmid][serval:BIB_EC6E5C623CB2]
 
Prévention des troubles du rythme cardiaque en hémodialyse: quels sont les facteurs modulables [Prevention of cardiac arrhythmias in hemodialysis: what are the modulating factors?].
Nowak G., El Housseini Y., Tataw Ashu J., Teta D., 2015/02. Revue Médicale Suisse, 11 (463) pp. 505-510.
[Pmid][serval:BIB_F7FDD686931E]
 
[112-POS] : Increased post-partum prevalence of hypertension and renal dysfunction after preeclampsia
Ditisheim A., Ponte B., Wuerzner G., Burnier M., Boulvain M., Pechère-Bertschi A., 2015. pp. 60-61 dans Abstracts from the XIXth World Congress of the ISSHP, 26-29 October 2014, New Orleans, LA, USA.
[DOI][Pmid][serval:BIB_97FBA38B5F53]
A prospective observational study comparing a non-operator dependent automatic PWV analyser to pulse pressure, in assessing arterial stiffness in hemodialysis.
Salvadé I., Schätti-Stählin S., Violetti E., Schönholzer C., Cereghetti C., Zwahlen H., Berwert L., Burnier M., Gabutti L., 2015. Bmc Nephrology, 16 (1) p. 62. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B9CAA9B324E5]
 
Antihypertensive Combination Treatment: State of the Art.
Burnier M., 2015. Current Hypertension Reports, 17 (7) p. 51. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_20D7447BC5F6]
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments.
Saigi-Morgui N., Vandenberghe F., Delacrétaz A., Quteineh L., Choong E., Gholamrezaee M., Magistretti P., Aubry J.M., von Gunten A., Preisig M. et al., 2015. Journal of Clinical Psychopharmacology, 35 (5) pp. 544-552. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65A415095D9E]
 
Associations of ambulatory blood pressure with urinary caffeine and caffeine metabolite excretions.
Guessous I., Pruijm M., Ponte B., Ackermann D., Ehret G., Ansermot N., Vuistiner P., Staessen J., Gu Y., Paccaud F. et al., 2015. Hypertension, 65 (3) pp. 691-696. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C5A6ADCBDFAD]
 
Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
Ewen S., Meyer M.R., Cremers B., Laufs U., Helfer A.G., Linz D., Kindermann I., Ukena C., Burnier M., Wagenpfeil S. et al., 2015. Clinical Research In Cardiology : Official Journal of the German Cardiac Society, 104 (12) pp. 1097-1105. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_697C420670D8]
 
Cadmium body burden of the Swiss population.
Jenny-Burri J., Haldimann M., Brüschweiler B.J., Bochud M., Burnier M., Paccaud F., Dudler V., 2015. Food Additives and Contaminants. Part A, Chemistry, Analysis, Control, Exposure and Risk Assessment, 32 (8) pp. 1265-1272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DAA73D49FCD5]
 
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study.
Möller B., Pruijm M., Adler S., Scherer A., Villiger P.M., Finckh A., Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) Foundation CH-8048 Zurich Switzerland, 2015. Annals of the Rheumatic Diseases, 74 (4) pp. 718-723. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8963929DA430]
 
Comparative Effect of a Renin Inhibitor and a Thiazide Diuretic on Renal Tissue Oxygenation in Hypertensive Patients.
Vakilzadeh N., Muller M.E., Forni V., Milani B., Hoffman L., Piskunowicz M., Maillard M., Zweiacker C., Pruijm M., Burnier M., 2015. Kidney and Blood Pressure Research, 40 (5) pp. 542-554. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3EA18BB8ACD]
 
Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.
Ponte B., Pruijm M., Ackermann D., Vuistiner P., Guessous I., Ehret G., Alwan H., Youhanna S., Paccaud F., Mohaupt M. et al., 2015. Journal of the American Society of Nephrology : Jasn, 26 (6) pp. 1415-1425. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_71C4D07716AD]
Drug adherence in chronic kidney diseases and dialysis.
Burnier M., Pruijm M., Wuerzner G., Santschi V., 2015. Nephrology, Dialysis, Transplantation, 30 (1) pp. 39-44. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_956823FFF7CC]
Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Phan O., Maillard M., Malluche H.H., Stehle J.C., Funk F., Burnier M., 2015. Biomed Research International, 2015 p. 515606. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C757FFF0A021]
ENaC activity in collecting ducts modulates NCC in cirrhotic mice.
Mordasini D., Loffing-Cueni D., Loffing J., Beatrice R., Maillard M.P., Hummler E., Burnier M., Escher G., Vogt B., 2015. Pflügers Archiv : European Journal of Physiology, 467 (12) pp. 2529-2539. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EEAFFA21DE0F]
Epithelial Sodium Channel-Mediated Sodium Transport Is Not Dependent on the Membrane-Bound Serine Protease CAP2/Tmprss4.
Keppner A., Andreasen D., Mérillat A.M., Bapst J., Ansermet C., Wang Q., Maillard M., Malsure S., Nobile A., Hummler E., 2015. Plos One, 10 (8) pp. e0135224. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0EC60EC08C02]
 
Evidence for pharmacist care in the management of hypertension
Santschi V., Tsuyuki R.T., Paradis G., 2015. Canadian Pharmacists Journal : Cpj, 148 (1) pp. 13-16. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_571A3F62DF9F]
Extraskeletal Functions of Vitamin D.
Santoro D., Sebekova K., Teta D., De Nicola L., 2015. Biomed Research International, 2015 p. 294719.
[URN][DOI][WoS][Pmid][serval:BIB_B0C046BDF3F9]
 
Inactive Matrix Gla-Protein is associated with arterial stiffness in an adult population-based study
Pivin E., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Liu Y.P., Drummen N.E., Knapen M.H., Pechere-Bertschi A. et al., 2015. Hypertension, 66 (1) pp. 85-92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5A885D1E1E5B]
 
Insulin Resistance as a Therapeutic Target for Chronic Kidney Disease.
Teta D., 2015. Journal of Renal Nutrition, 25 (2) pp. 226-229. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30B6482304C2]
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system.
Santoro D., Caccamo D., Lucisano S., Buemi M., Sebekova K., Teta D., De Nicola L., 2015. Biomed Research International, 2015 p. 145828.
[URN][DOI][WoS][Pmid][serval:BIB_A4C535FEA3C1]
IRC préterminale : il n'est jamais trop tôt pour référer au spécialiste : Revue cochrane pour le praticien
Beaud F., Pruijm M., Peytremann-Bridevaux I., 2015. Revue Médicale Suisse 493 p. 2085.
[URN][serval:BIB_CA175B6E9050]
 
L'insuffisance rénale chronique: quelle est la diète optimale
Lu Y., Vakilzadeh N., Teta D., 2015. Praxis, 104 (7) pp. 361-367.
[DOI][Pmid][serval:BIB_8A130A84145B]
 
La nephrologie en médecine de premier recours: une tâche quotidienne pour le médecin de premier recours ou un domaine réservé au specialist [Nephrology in primary care medicine: routine management for the primary care physician or an area reserved for the specialist?].
Wuerzner G., 2015. Praxis, 104 (7) p. 321. Peer-reviewed.
[DOI][Pmid][serval:BIB_B33B4E18F2DE]
 
Loss of DGKepsilon induces endothelial cell activation and death independently of complement activation
Bruneau S., Neel M., Roumenina L. T., Frimat M., Laurent L., Fremeaux-Bacchi V., Fakhouri F., 2015. Blood, 125 (6) pp. 1038-46.
[DOI][Pmid][serval:BIB_41EB8D040D5A]
 
Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension
Zhu X., Feng T., Tayo B.O., Liang J., Young J.H., Franceschini N., Smith J.A., Yanek L.R., Sun Y.V., Edwards T.L. et al., 2015. American Journal of Human Genetics, 96 (1) pp. 21-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75E1E9707098]
Modulation of genetic associations with serum urate levels by body-mass-index in humans.
Huffman J.E., Albrecht E., Teumer A., Mangino M., Kapur K., Johnson T., Kutalik Z., Pirastu N., Pistis G., Lopez L.M. et al., 2015. Plos One, 10 (3) pp. e0119752. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E8D96115B4D8]
New genetic loci link adipose and insulin biology to body fat distribution.
Shungin D., Winkler T.W., Croteau-Chonka D.C., Ferreira T., Locke A.E., Mägi R., Strawbridge R.J., Pers T.H., Fischer K., Justice A.E. et al., 2015. Nature, 518 (7538) pp. 187-196. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10C25BFE14DB]
 
Obstructive Sleep Apnea Severity and Overnight Body Fluid Shift before and after Hemodialysis.
Ogna A., Forni Ogna V., Mihalache A., Pruijm M., Halabi G., Phan O., Cornette F., Bassi I., Haba Rubio J., Burnier M. et al., 2015. Clinical Journal of the American Society of Nephrology : Cjasn, 10 (6) pp. 1002-1010. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24E31BAB288B]
 
Pathophysiology of Hypertension
Burnier Michel, Wuerzner Grégoire, 2015. 15.
[DOI][serval:BIB_6565AF261F40]
 
Performance of parental history for the targeted screening of hypertension in children.
Bloetzer C., Paccaud F., Burnier M., Bovet P., Chiolero A., 2015. Journal of Hypertension, 33 (6) pp. 1167-1173. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E2331368CD6]
 
Phenotypes influencing low physical activity in maintenance dialysis.
Panaye M., Kolko-Labadens A., Lasseur C., Paillasseur J.L., Guillodo M.P., Levannier M., Teta D., Fouque D., 2015/01. Journal of Renal Nutrition, 25 (1) pp. 31-39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_666BBAE40E1E]
 
Post-partum persistence of abnormal circadian pattern of blood pressure after preeclampsia [109-POS]
Ditisheim A., Ponte B., Wuerzner G., Burnier M., Boulvain M., Pechère-Bertschi A., 2015/01. p. 59 dans XIXth World Congress for the Study of Hypertension in Pregnancy Preeclampsia/Hypertension: Future Risks and Novel Therapies, International Journal of Women's Cardiovascular Health.
[DOI][Pmid][serval:BIB_90B6408AC69D]
 
Preterminal chronic renal failure: It is never too early to refer to the specialist,IRC préterminale: Il n'est jamais trop tôt pour référer au spécialiste
Pruijm Menno, 2015. Revue Medicale Suisse.
[serval:BIB_29131F97358A]
Prevalence and Diagnostic Approach to Sleep Apnea in Hemodialysis Patients: A Population Study.
Forni Ogna V., Ogna A., Pruijm M., Bassi I., Zuercher E., Halabi G., Phan O., Bullani R., Teta D., Gauthier T. et al., 2015. Biomed Research International, 2015 p. 103686.
[URN][DOI][WoS][Pmid][serval:BIB_FD7B90AC94CA]
Prevalence of iodine inadequacy in Switzerland assessed by the estimated average requirement cut-point method in relation to the impact of iodized salt.
Haldimann M., Bochud M., Burnier M., Paccaud F., Dudler V., 2015. Public Health Nutrition, 18 (8) pp. 1333-1342. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DA413027D74B]
 
Prise en charge des facteurs de risque des maladies cardiovasculaires: qu'est-ce qui a vraiment changé en 15 ans [Management of cardiovascular diseases in adults from 1999 to 2014: what has really changed?].
Barthel C., Nanchen D., Jornayvaz F.R., Wuerzner G., Senn N., 2015. Revue Médicale Suisse, 11 (496) pp. 2228, 2230-2228, 2235. Peer-reviewed.
[Pmid][serval:BIB_00C3BE9BD61E]
 
Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients.
Chazot C., Farrington K., Nistor I., Van Biesen W., Joosten H., Teta D., Siriopol D., Covic A., 2015. International Urology and Nephrology, 47 (11) pp. 1809-1816. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0B047E147BD]
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.
Mahfoud F., Böhm M., Azizi M., Pathak A., Durand Zaleski I., Ewen S., Tsioufis K., Andersson B., Blankestijn P.J., Burnier M. et al., 2015. European Heart Journal, 36 (33) pp. 2219-2227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_460EB6ADDAF6]
Salt, blood pressure and cardiovascular risk : what is the most adequate preventive strategy? A Swiss perspective
Burnier M., Wuerzner G., Bochud M., 2015. Frontiers in Physiology, 6 p. 227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50BB266EB559]
Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty.
Halfon M., Phan O., Teta D., 2015. BioMed Research International, 2015 p. 953241.
[URN][DOI][WoS][Pmid][serval:BIB_53A767909B78]
2014
 
Hypertension et adhérence thérapeutique: un challenge de tous les jours [Hypertension and medication compliance: a challenge every day]
Vuignier Y., Burnier M., Waeber B., Wuerzner G., 2014/12/10. Praxis, 103 (25) pp. 1515-1519. Peer-reviewed.
[DOI][Pmid][serval:BIB_E33B5272F7E7]
 
Blood pressure monitoring through pharmacies and team-based care of hypertension.
Santschi V., Wurzner G., Chiolero A., 2014/12. Blood Pressure Monitoring, 19 (6) p. 371. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5E2103161458]
 
Hypertension in Chronic Kidney Disease - Role of Arterial Calcification and Impact on Treatment.
Phan O., Burnier M., Wuerzner G., 2014/12. European cardiology, 9 (2) pp. 115-119. Peer-reviewed.
[DOI][Pmid][serval:BIB_E57B54E0E887]
Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.
Deutz N.E., Bauer J.M., Barazzoni R., Biolo G., Boirie Y., Bosy-Westphal A., Cederholm T., Cruz-Jentoft A., Krznariç Z., Nair K.S. et al., 2014/12. Clinical Nutrition, 33 (6) pp. 929-936. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F0773554B38]
 
Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance
Guitard J., Hebral A. L., Fakhouri F., Joly D., Daugas E., Rivalan J., Guigonis V., Ducret F., Presne C., Pirson Y. et al., 2014/11. Nephrol Dial Transplant, 29 (11) pp. 2084-91.
[DOI][Pmid][serval:BIB_7B09C484785D]
Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot study.
Zanchi A., Tappy L., Lê K.A., Bortolotti M., Theumann N., Halabi G., Gauthier T., Mathieu C., Tremblay S., Bertrand P.C. et al., 2014/10. Plos One, 9 (10) pp. e109134. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1D97934B1629]
 
Antidiabétiques et insuffisance rénale
Lamine Faiza, Philippe Jacques, Zanchi Anne, 2014/09. MCED, 72 pp. 21-27.
[serval:BIB_A5941B08216C]
 
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., Silani V., Bilo G., Corrao G., Zambon A. et al., 2014/09. Journal of hypertension, 32 (9) pp. 1888-1897.
[DOI][Pmid][serval:BIB_D29ACD0470B8]
 
Femmes actuelles [Present day's women].
Ditisheim A., 2014/09. Revue Médicale Suisse, 10 (441) p. 1643.
[Pmid][serval:BIB_F2D8BDE3A538]
 
Malignancy and thrombotic microangiopathy or atypical haemolytic and uraemic syndrome?
Favre G. A., Touzot M., Fremeaux-Bacchi V., Hyvernat H., Gueffet J. P., Rohrlich P. S., Queyrel V., Esnault V., Fakhouri F., 2014/09. Br J Haematol, 166 (5) pp. 802-5.
[DOI][Pmid][serval:BIB_657A54C83025]
 
Meédicaments: une cause sous-estimée d'hypertension artérielle [Drugs: an underestimated cause of arterial hypertension].
Serveaux M., Burnier M., Pruijm M., 2014/09. Revue Médicale Suisse, 10 (441) pp. 1661-2, 1664-5.
[Pmid][serval:BIB_D05EC0C0C042]
 
Nouveaux aspects de la prise en charge de l'hypertension artérielle chez le patient insuffisant rénal chronique [New aspects of hypertension management in patients with chronic kidney disease].
Vakilzadeh N., Phan O., Ogna V.F., Burnier M., Wuerzner G., 2014/09. Revue Médicale Suisse, 10 (441) pp. 1668-1672.
[Pmid][serval:BIB_D1A2B0FA6384]
Circadian glomerular function: from physiology to molecular and therapeutical aspects.
Wuerzner G., Firsov D., Bonny O., 2014/08. Nephrology, Dialysis, Transplantation, 29 (8) pp. 1475-1480. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E802728E85FB]
Prevalence of obesity and overweight and associated nutritional factors in a population-based Swiss sample: an opportunity to analyze the impact of three different European cultural roots.
Ogna A., Forni Ogna V., Bochud M., Paccaud F., Gabutti L., Burnier M., Swiss Survey on Salt Group, 2014/08. European journal of nutrition, 53 (5) pp. 1281-1290. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6C23A1B8A38F]
 
Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1
Lavainne F., Meffray E., Pepper R. J., Neel M., Delcroix C., Salama A. D., Fakhouri F., 2014/06. Nephrol Dial Transplant, 29 (6) pp. 1225-31.
[DOI][Pmid][serval:BIB_F33F41FF184E]
 
Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches
Riedl M., Fakhouri F., Le Quintrec M., Noone D. G., Jungraithmayr T. C., Fremeaux-Bacchi V., Licht C., 2014/06. Semin Thromb Hemost, 40 (4) pp. 444-64.
[DOI][Pmid][serval:BIB_E8592A26C04A]
 
Assessment of subjective and hemodynamic tolerance of different high- and low-flux dialysis membranes in patients undergoing chronic intermittent hemodialysis: a randomized controlled trial.
Bianchi G., Salvadé V., Lucchini B., Schätti-Stählin S., Salvadé I., Burnier M., Gabutti L., 2014/05. Hemodialysis International. International Symposium on Home Hemodialysis, 18 (4) pp. 825-834.
[DOI][WoS][Pmid][serval:BIB_27980115BCDC]
Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans.
Pruijm M., Hofmann L., Piskunowicz M., Muller M.E., Zweiacker C., Bassi I., Vogt B., Stuber M., Burnier M., 2014/04. Plos One, 9 (4) pp. e95895. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CA1F4EDF7F3]
 
Interprétation de la volémie dans l'insuffisance rénale aiguë [Interpretation of volemia in acute kidney injury].
Serveaux M., Burnier M., Kissling S., 2014/02. Revue Médicale Suisse, 10 (419) pp. 474-6, 478-9.
[Pmid][serval:BIB_41921E070392]
 
Long-term outcome of monoclonal (type 1) cryoglobulinemia
Neel A., Perrin F., Decaux O., Dejoie T., Tessoulin B., Halliez M., Mahe B., Lamy T., Fakhouri F., Jego P. et al., 2014/02. Am J Hematol, 89 (2) pp. 156-61.
[DOI][Pmid][serval:BIB_F0F61F73F24E]
 
Maladies vasculaires rares [Rare vascular diseases].
Calanca L., Depairon M., Tribout B., Aebischer N., Burnier M., Fellmann F., Lazor R., Mazzolai L., 2014/02. Revue Médicale Suisse, 10 (416) pp. 347-50, 352.
[Pmid][serval:BIB_D39C18EC277E]
 
Nouvelles approches dans l'insuffisance rénale aiguë et les vascularites [New approaches in acute kidney insufficiency and vasculitides ].
Burnier M., Martin P.Y., 2014/02. Revue Médicale Suisse, 10 (419) pp. 467-468.
[Pmid][serval:BIB_5E2A641238C2]
 
Risques rénaux des compléments alimentaires: une cause ignorée [Renal risks of dietary complements: a forgotten cause].
Dori O., Humbert A., Burnier M., Teta D., 2014/02. Revue Médicale Suisse, 10 (419) pp. 498-503.
[Pmid][serval:BIB_C9E3F298663E]
 
Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension.
Burnier M., Wuerzner G., 2014. Seminars in Nephrology, 34 (5) pp. 498-505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E0D6D5B09C9]
 
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.
Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., Silani V., Bilo G., Corrao G., Zambon A. et al., 2014. Journal of Hypertension, 32 (9) pp. 1741-1750. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6B00E6772E4C]
Blood pressure and physical activity : time to move (on)
Wuerzner G., Bochud M., Burnier M., 2014. American Journal of Hypertension, 27 (8) p. 1125. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3AC2B1A0AABF]
Blood pressure changes after renal denervation at 10 European expert centers.
Persu A., Jin Y., Azizi M., Baelen M., Völz S., Elvan A., Severino F., Rosa J., Adiyaman A., Fadl Elmula F.E. et al., 2014. Journal of Human Hypertension, 28 (3) pp. 150-156. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_69AD7F628235]
Characteristics and treatment response of self-identified problematic Internet users in a behavioral addiction outpatient clinic
Thorens Gabriel, Achab Sophia, Billieux Joël, Khazaal Yasser, Khan Riaz, Pivin Edward, Gupta Vishal, Zullino Daniel, 2014. Journal of Behavioral Addictions, 3 (1) pp. 78-81. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_25F0845C1F8F]
 
Chronic kidney disease: Should sodium intake be restricted in patients with CKD?
Burnier M., Wuerzner G., 2014. Nature Reviews. Nephrology, 10 (7) pp. 363-364.
[DOI][WoS][Pmid][serval:BIB_D94F66E14666]
 
Clinical and biological determinants of kidney outcomes in a population-based cohort study
Guessous I., Ponte B., Marques-Vidal P., Paccaud F., Gaspoz J.M., Burnier M., Waeber G., Vollenweider P., Bochud M., 2014. Kidney and Blood Pressure Research, 39 (1) pp. 74-85. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_100057102FD2]
 
Colon-specific deletion of epithelial sodium channel causes sodium loss and aldosterone resistance.
Malsure S., Wang Q., Charles R.P., Sergi C., Perrier R., Christensen B.M., Maillard M., Rossier B.C., Hummler E., 2014. Journal of the American Society of Nephrology, 25 (7) pp. 1453-1464. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6A776DBC5063]
 
Comparisons of serum vitamin d levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study.
Guessous I., McClellan W., Kleinbaum D., Vaccarino V., Zoller O., Theler J.M., Paccaud F., Burnier M., Bochud M., Swiss Survey on Salt Group, 2014. Journal of Renal Nutrition, 24 (5) pp. 303-312. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50B6A25089E3]
 
Eligibility for renal denervation: experience at 11 European expert centers.
Persu A., Jin Y., Baelen M., Vink E., Verloop W.L., Schmidt B., Blicher M.K., Severino F., Wuerzner G., Taylor A. et al., 2014. Hypertension, 63 (6) pp. 1319-1325.
[DOI][WoS][Pmid][serval:BIB_29FDFC4186D3]
Epidemiology of Masked and White-Coat Hypertension: The Family-Based SKIPOGH Study.
Alwan H., Pruijm M., Ponte B., Ackermann D., Guessous I., Ehret G., Staessen J.A., Asayama K., Vuistiner P., Younes S.E. et al., 2014. Plos One, 9 (3) pp. e92522. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D41F9D70978B]
 
Etiological and Pathophysiological Aspects of Hypertension: Other Humoral-Endocrine Factors
Burnier M., 2014. pp. 149-158 dans Mancia G., Grassi G., Redon G (eds.) Manual of hypertension of the European Society of Hypertension chap. 16, CRC Press.
[serval:BIB_E95745F2B4C9]
Genetics of calcium homeostasis in humans: continuum between monogenic diseases and continuous phenotypes
Bonny O., Bochud M., 2014. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 29 (suppl 4) pp. iv55-iv62. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50A29581C88D]
 
Glomérulonéphrite rapidement progressive: une urgence diagnostique et thérapeutique [Rapidly progressive glomerulonephritis: a diagnostic and therapeutic emergency]
Halfon M., Teta D., Rotman S., Pruijm M., Humbert A., 2014. Revue Médicale Suisse, 10 (419) pp. 480-486.
[Pmid][serval:BIB_1CAD97685C1E]
 
Hyperresponders vs. nonresponder patients after renal denervation: do they differ?
Persu A., Azizi M., Jin Y., Volz S., Rosa J., Fadl Elmula F.E., Pechere-Bertschi A., Burnier M., Mark P.B., Elvan A. et al., 2014. Journal of Hypertension, 32 (12) pp. 2422-7; discussion 2427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1DDE970B2389]
 
Hypertension. L'enregistrement tensionnel en ambulatoire: indispensable pour diagnostiquer et traiter l'hypertension [Ambulatory blood pressure monitoring: essential for diagnosing and treating hypertension?].
Waeber B., Wuerzner G., 2014. Revue Médicale Suisse, 10 (412-413) pp. 57-8, 60.
[Pmid][serval:BIB_790FFE2F7689]
 
IGG4-Related disease: nephrologic aspects and review
Seyde O., Humbert A., Teta D., Gauthier T., Hemett OM, Descombes E., Rotman S., 2014. dans 80th annual congress of the Swiss Society of Pathology.
[serval:BIB_D65825FF6364]
Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.
Santschi V., Chiolero A., Colosimo A.L., Platt R.W., Taffé P., Burnier M., Burnand B., Paradis G., 2014. Journal of the American Heart Association, 3 (2) pp. e000718. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5843DF507CB0]
 
Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases
Fakhouri F., Delmas Y., Provot F., Barbet C., Karras A., Makdassi R., Courivaud C., Rifard K., Servais A., Allard C. et al., 2014/01. Am J Kidney Dis, 63 (1) pp. 40-8.
[DOI][Pmid][serval:BIB_8CEB2913341B]
Local Renal Circadian Clocks Control Fluid-Electrolyte Homeostasis and BP.
Tokonami N., Mordasini D., Pradervand S., Centeno G., Jouffe C., Maillard M., Bonny O., Gachon F., Gomez R.A., Sequeira-Lopez M.L. et al., 2014. Journal of the American Society of Nephrology, 25 (7) pp. 1430-1439.
[URN][DOI][WoS][Pmid][serval:BIB_98248DEAD541]
 
Managing 'resistance': is adherence a target for treatment?
Burnier M., 2014. Current Opinion in Nephrology and Hypertension, 23 (5) pp. 439-443.
[DOI][WoS][Pmid][serval:BIB_728A6385CA2C]
 
Medical Treatment of Hypertension: Monotherapy and Combination Therapy
M. Burnier , G. Wuerzner , B. Waeber , 2014. pp. 309-318 dans Mancia G., Grassi G., Redon G (eds.) Manual of hypertension of the European Society of Hypertension, CRC Press.
[serval:BIB_04CBA45353CF]
 
Performance of blood pressure-to-height ratio at a single screening visit for the identification of hypertension in children.
Outdili Z., Marti-Soler H., Simonetti G.D., Bovet P., Paccaud F., Burnier M., Paradis G., Chiolero A., 2014. Journal of Hypertension, 32 (5) pp. 1068-74; discussion 1074. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5D6893C6A906]
Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.
Cozzolino M., Funk F., Rakov V., Phan O., Teitelbaum I., 2014. Current Drug Metabolism, 15 (10) pp. 953-965. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_7E7363931E00]
 
Reference values and factors associated with renal resistive index in a family-based population study.
Ponte B., Pruijm M., Ackermann D., Vuistiner P., Eisenberger U., Guessous I., Rousson V., Mohaupt M.G., Alwan H., Ehret G. et al., 2014. Hypertension, 63 (1) pp. 136-142. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DDF68E1C8890]
 
Response to maximizing treatment adherence: physician-patient partnerships vs procedures.
Burnier M., Wuerzner G., Boudier H.S., Urquhart J., 2014. Hypertension, 63 (2) pp. e8.
[WoS][Pmid][serval:BIB_77212E404F39]
State-of-the-art treatment of hypertension: established and new drugs.
Burnier M., Vuignier Y., Wuerzner G., 2014. European Heart Journal, 35 (9) pp. 557-562. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_45A42B7B60D6]
The spectrum of renal involvement in patients with inflammatory myopathies
Couvrat-Desvergnes G., Masseau A., Benveniste O., Bruel A., Hervier B., Mussini J. M., Buob D., Hachulla E., Remy P., Azar R. et al., 2014/01. Medicine (Baltimore), 93 (1) pp. 33-41.
[URN][DOI][Pmid][serval:BIB_F6CC2AEA9E23]
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus.
Wuerzner G., Muller O., Erne P., Cook S., Sudano I., Lüscher T.F., Noll G., Kaufmann U., Rickli H., Waeber B. et al., 2014. Swiss Medical Weekly, 144 pp. w13913.
[URN][DOI][Pmid][serval:BIB_B279E13B1B71]
2013
C3 glomerulopathy: consensus report
Pickering M. C., D'Agati V. D., Nester C. M., Smith R. J., Haas M., Appel G. B., Alpers C. E., Bajema I. M., Bedrosian C., Braun M. et al., 2013/12. Kidney Int, 84 (6) pp. 1079-89.
[URN][DOI][Pmid][serval:BIB_D033D6592E29]
 
Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen
Allavena C., Bach-Ngohou K., Billaud E., Secher S., Dejoie T., Reliquet V., Fakhouri F., Raffi F., 2013/12. J Antimicrob Chemother, 68 (12) pp. 2866-70.
[DOI][Pmid][serval:BIB_AEFB9AEE2739]
 
Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy
Fakhouri F., Fremeaux-Bacchi V., Loirat C., 2013/09. Eur J Intern Med, 24 (6) pp. 492-5.
[DOI][Pmid][serval:BIB_F58C4C20E4EF]
 
Thrombotic microangiopathy: eculizumab for atypical haemolytic uraemic syndrome: what next?
Fakhouri F., Fremeaux-Bacchi V., 2013/09. Nat Rev Nephrol, 9 (9) pp. 495-6.
[DOI][Pmid][serval:BIB_6AD330B5FF54]
 
No use for waist-for-height ratio in addition to body mass index to identify children with elevated blood pressure.
Chiolero A., Paradis G., Maximova K., Burnier M., Bovet P., 2013/07. Blood Pressure, 22 (1) pp. 17-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_907C0FB3DCA0]
 
Verbessern Arzneimittel-Einnahmehilfen die Compliance [Do drug taking aids improve compliance?].
Santschi V., Burnier M., Peytremann-Bridevaux I., 2013/06. Praxis, 102 (13) pp. 807-808.
[DOI][Pmid][serval:BIB_5922D2C9F9D5]
Two new families with hereditary minimal change disease.
Chehade H., Cachat F., Girardin E., Rotman S., Correia A.J., Fellmann F., Bonny O., 2013/03/22. BMC nephrology, 14 p. 65. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF1B2E1F0453]
 
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A. et al., 2013. Journal of Hypertension, 31 (7) pp. 1281-1357. Peer-reviewed.
[DOI][Pmid][serval:BIB_FA1435B1D6AF]
 
Approche pratique de la lithiase rénale: duo entre généralistes et spécialistes [Renal stone disease: collaborative management between primary care and specialized physicians].
Ernandez T., Stoermann Chopard C., Bonny O., Iselin C., Martin P.Y., Jaeger P., 2013. Revue Médicale Suisse, 9 (375) pp. 456-461.
[Pmid][serval:BIB_7DE2F465D8CB]
Association of calcemia and serum vitamin D with 24H-urinary calcium excretion in a swiss population-based study
Rathod A., Bonny O., Guessous I., Suter P.M., Conen D., Erne P., Péchère-Bertschi A., Paccaud F., Burnier M., Bochud M., 2013. dans Swiss Public Health Conference 2013.
[URN][serval:BIB_ECBB1BF0083C]
 
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes.
Pruijm M., Hofmann L., Zanchi A., Maillard M., Forni V., Muller M.E., Wuerzner G., Vogt B., Stuber M., Burnier M., 2013. Diabetes Research and Clinical Practice, 99 (2) pp. 136-144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EB1FB150E41F]
 
Blockade of the Renin-Angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.
Jarraya F., Pruijm M., Wuerzner G., Burnier M., 2013. Current Hypertension Reports, 15 (5) pp. 497-505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D83473F0E104]
 
C.F. Ramuz, Notes anciennes et textes retrouvés
Delacrétaz A.-L., Gaetzi C., Maggetti D., Pétermann S., Saggiorato L. (eds.), 2013. C.F. Ramuz, Oeuvres complètes, XXIX 510, Slatkine.
[serval:BIB_AE40668B64D3]
 
Calcifications vasculaires et déficit en vitamine K: un facteur de risque modifiable dans l'insuffisance rénale chronique [Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease].
Phan O., Burnier M., 2013. Revue Médicale Suisse, 9 (375) pp. 451-455.
[Pmid][serval:BIB_7C0C1CCD579B]
 
Calcium reabsorption in the distal tubule: regulation by sodium, pH, and flow.
Bonny O., Edwards A., 2013. American Journal of Physiology., 304 (5) pp. F585-F600.
[DOI][WoS][Pmid][serval:BIB_9C6D71787642]
Circadian regulation of renal function and potential role in hypertension.
Bonny O., Firsov D., 2013. Current Opinion In Nephrology and Hypertension, 22 (4) pp. 439-444.
[URN][DOI][WoS][Pmid][serval:BIB_D33E7C4F56F6]
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study.
Forni Ogna V., Pruijm M., Zweiacker C., Wuerzner G., Tousset E., Burnier M., 2013. Biomed Research International, 2013 p. 104892.
[URN][DOI][WoS][Pmid][serval:BIB_1C759E046A85]
Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.
Trudu M., Janas S., Lanzani C., Debaix H., Schaeffer C., Ikehata M., Citterio L., Demaretz S., Trevisani F., Ristagno G. et al., 2013. Nature Medicine, 19 (12) pp. 1655-1660.
[URN][DOI][WoS][Pmid][serval:BIB_C399FC2ECDDE]
Common variants associated with plasma triglycerides and risk for coronary artery disease.
Do R., Willer C.J., Schmidt E.M., Sengupta S., Gao C., Peloso G.M., Gustafsson S., Kanoni S., Ganna A., Chen J. et al., 2013. Nature Genetics, 45 (11) pp. 1345-1352.
[URN][DOI][WoS][Pmid][serval:BIB_5CA22C7D515E]
Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis.
Ponte B., Pruijm M., Marques-Vidal P., Martin P.Y., Burnier M., Paccaud F., Waeber G., Vollenweider P., Bochud M., 2013. Nephrology, Dialysis, Transplantation, 28 (9) pp. 2329-2339. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3AE2E237896D]
 
Dialyse et écologie: est-il possible de faire mieux à l'avenir [Dialysis and ecology: can we do better in the future?].
Vuignier Y., Pruijm M., Jarrayah F., Burnier M., 2013. Revue Médicale Suisse, 9 (375) pp. 468-472.
[Pmid][serval:BIB_56923B136FD8]
Discovery and refinement of loci associated with lipid levels.
Global Lipids Genetics Consortium, Willer C.J., Willer C.J., Schmidt E.M., Sengupta S., Peloso G.M., Gustafsson S., Kanoni S., Ganna A., Chen J. et al., 2013. Nature Genetics, 45 (11) pp. 1274-1283.
[URN][DOI][WoS][Pmid][serval:BIB_4F479093D7BD]
 
Effect of dark chocolate on renal tissue oxygenation as measured by BOLD-MRI in healthy volunteers.
Pruijm M., Hofmann L., Charollais-Thoenig J., Forni V., Maillard M., Coristine A., Stuber M., Burnier M., Vogt B., 2013. Clinical Nephrology, 80 (9) pp. 211-217.
[DOI][WoS][Pmid][serval:BIB_CC4322D153E9]
 
Epuration extrarénale continue pour l'insuffisance rénale aiguë aux soins intensifs [Continuous renal replacement therapy for acute kidney injury].
Aymon L., Kissling S., Revelly J.P., Que Y.A., Schneider A.G., 2013. Revue Médicale Suisse, 9 (410) pp. 2324, 2326-2324, 2329.
[Pmid][serval:BIB_6D6A3844AD56]
 
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group.
Bauer J., Biolo G., Cederholm T., Cesari M., Cruz-Jentoft A.J., Morley J.E., Phillips S., Sieber C., Stehle P., Teta D. et al., 2013. Journal of the American Medical Directors Association, 14 (8) pp. 542-559. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BCF4F619FAE1]
Factors associated with 24-hour urinary volume: the Swiss salt survey.
Schoen T., Blum J., Paccaud F., Burnier M., Bochud M., Conen D., Swiss Survey on Salt investigators, 2013. Bmc Nephrology, 14 (246) p. 246.
[URN][DOI][WoS][Pmid][serval:BIB_0B7980CDD959]
 
Fish oil for prevention of sudden death in hemodialysis patients?
Teta D., 2013. Kidney International, 83 (6) pp. 993-995.
[DOI][WoS][Pmid][serval:BIB_85671B102F1D]
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
Köttgen A., Albrecht E., Teumer A., Vitart V., Krumsiek J., Hundertmark C., Pistis G., Ruggiero D., O'Seaghdha C.M., Haller T. et al., 2013. Nature Genetics, 45 (2) pp. 145-154. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_772703318942]
 
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations.
Franceschini N., Fox E., Zhang Z., Edwards T.L., Nalls M.A., Sung Y.J., Tayo B.O., Sun Y.V., Gottesman O., Adeyemo A. et al., 2013. American Journal of Human Genetics, 93 (3) pp. 545-554.
[DOI][WoS][Pmid][serval:BIB_8CA92D98BCC9]
Hemodialysis for cefepime intoxication: A case report
Mani L.Y., Kissling S., Burnier M., Buclin T., Renard D., 2013. pp. e24 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
[URN][serval:BIB_E4B72FAAFE84]
Heritability of blood pressure in the swiss population: the family-based skipogh study
Alwan H., Ehret G., Ponte B., Pruijm M., Ackermann D., Guessous I., Pechère-Bertschi A., Paccaud F., Burnier M, Bochud M., 2013. dans Swiss Public Health Conference 2013.
[URN][serval:BIB_D9C8C0F19244]
Heritability, determinants and reference values of renal length: a family-based population study.
Pruijm M., Ponte B., Ackermann D., Vuistiner P., Paccaud F., Guessous I., Ehret G., Eisenberger U., Mohaupt M., Burnier M. et al., 2013. European Radiology, 23 (10) pp. 2899-2905. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0208A4ED3843]
 
Hyperaldostéronisme primaire sur adénome ou hyperplasie de la surrénale: opérer ou non [Primary hyperaldosteronism with adrenal adenoma or hyperplasia: surgical case or not?].
Muller M.E., Doenz F., Matter M., Wuerzner G., Burnier M., 2013. Revue Médicale Suisse, 9 (397) pp. 1633-1638.
[Pmid][serval:BIB_AB8114993EC9]
 
Hypertension: les nouvelles recommandations européennes sont arrivées ! TA l 140/90 mmHg pour tous [Hypertension: new European guidelines have have arrived! BP <140/90 mmHg for all].
Burnier M., Bertschi A.P., Waeber B., 2013. Revue Médicale Suisse, 9 (397) p. 1611.
[Pmid][serval:BIB_0E643C9BFF30]
 
Impact de la consommation de sel sur la santé: les croyances de la population suisse [Impact of salt intake on health: beliefs of the Swiss population].
Ditisheim A., Muradbegovic E., Bochud M., Burnier M., Pechère-Bertschi A., 2013. Revue Médicale Suisse, 9 (397) pp. 1613-1616.
[Pmid][serval:BIB_70A0C71C6C9C]
 
Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia.
Martillotti G., Ditisheim A., Burnier M., Wagner G., Boulvain M., Irion O., Pechère-Bertschi A., 2013. Hypertension, 62 (4) pp. 802-808.
[DOI][WoS][Pmid][serval:BIB_DE8F753CB297]
 
Increased soluble Flt-1 correlates with delayed graft function and early loss of peritubular capillaries in the kidney graft
Chapal M., Neel M., Le Borgne F., Meffray E., Carceles O., Hourmant M., Giral M., Foucher Y., Moreau A., Fakhouri F., 2013. Transplantation, 96 (8) pp. 739-44.
[DOI][Pmid][serval:BIB_B23A6CD6EDA0]
 
Inflammatory markers and blood pressure: sex differences and the effect of fat mass in the CoLaus Study.
Pruijm M., Vollenweider P., Mooser V., Paccaud F., Preisig M., Waeber G., Marques-Vidal P., Burnier M., Bochud M., 2013. Journal of Human Hypertension, 27 (3) pp. 169-175.
[DOI][WoS][Pmid][serval:BIB_08B527D955B7]
 
La guerre du sel : utilité et limites des revues Cochrane
Bochud M., Burnier M., Paccaud F., 2013. Revue Médicale Suisse, 9 pp. 2192-2193.
[serval:BIB_1DD312E4FFBE]
 
La vitesse de l'onde de pouls et la pression artérielle centrale devraient-elles être mesurées chez les patients hypertendus
Muller M.E., Zimmerli L., Burnier M., Wuerzner G., 2013. Praxis, 102 (9) pp. 529-533.
[DOI][Pmid][serval:BIB_FC6595146DB8]
 
Lack of Enantioselectivity in the SULT1A3-catalyzed Sulfoconjugation of Normetanephrine Enantiomers: An In Vitro and Computational Study.
Grouzmann E., Gualtierotti J.B., Gerber-Lemaire S., Abid K., Brakch N., Pedretti A., Testa B., Vistoli G., 2013. Chirality, 25 pp. 28-34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA02AD236F60]
 
Measuring, analyzing, and managing drug adherence in resistant hypertension.
Burnier M., Wuerzner G., Struijker-Boudier H., Urquhart J., 2013. Hypertension, 62 (2) pp. 218-225.
[DOI][WoS][Pmid][serval:BIB_14FD3B18E2AD]
Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.
O'Seaghdha C.M., Wu H., Yang Q., Kapur K., Guessous I., Zuber A.M., Köttgen A., Stoudmann C., Teumer A., Kutalik Z. et al., 2013. Plos Genetics, 9 (9) pp. e1003796.
[URN][DOI][WoS][Pmid][serval:BIB_2AD446B425B4]
Mice carrying ubiquitin-specific protease 2 (Usp2) gene inactivation maintain normal sodium balance and blood pressure.
Pouly D., Debonneville A., Ruffieux-Daidié D., Maillard M., Abriel H., Loffing J., Staub O., 2013. American Journal of Physiology. Renal Physiology, 305 (1) pp. F21-F30. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_804E17E149C1]
Molecular bases of circadian rhythmicity in renal physiology and pathology.
Bonny O., Vinciguerra M., Gumz M.L., Mazzoccoli G., 2013. Nephrology, Dialysis, Transplantation, 28 (10) pp. 2421-2431.
[URN][DOI][WoS][Pmid][serval:BIB_D4E58F4B31B0]
 
Nouvelles recommandations de l'ESH/ESC: des changements en douceur pour le malade hypertendu [New recommendations of the ESH/ESC: smooth changes for the hypertensive patient].
Waeber B., Wuerzner G., 2013. Revue Médicale Suisse, 9 (397) pp. 1639-1644.
[Pmid][serval:BIB_FC8D8A3CABA6]
 
Néphropathie au produit de contraste [Contrast-induced nephropathy].
Humbert A., Kissling S., Teta D., 2013. Revue Médicale Suisse, 9 (389) pp. 1222-1228.
[Pmid][serval:BIB_B4F783592535]
 
Oscillometric blood pressure reference values in children.
Chiolero Arnaud, Bovet Pascal, Burnier Michel, 2013. Journal of Hypertension, 31 (2) p. 426. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D51216FC5CDB]
 
PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats.
Phan O., Maillard M., Peregaux C., Mordasini D., Stehle J.C., Funk F., Burnier M., 2013. Journal of Pharmacology and Experimental Therapeutics, 346 (2) pp. 281-289.
[DOI][WoS][Pmid][serval:BIB_9B3FF62DF72B]
 
Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in swiss primary care.
Schäfer H.H., de Villiers J.D., Lotze U., Sivukhina E., Burnier M., Noll G., Theus G.R., Dieterle T., 2013. Clinical and Experimental Hypertension, 35 (7) pp. 496-505.
[DOI][WoS][Pmid][serval:BIB_0D7BC4D6702A]
 
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism.
Ikizler T.A., Cano N.J., Franch H., Fouque D., Himmelfarb J., Kalantar-Zadeh K., Kuhlmann M.K., Stenvinkel P., Terwee P., Teta D. et al., 2013. Kidney International, 84 (6) pp. 1096-1107.
[DOI][WoS][Pmid][serval:BIB_3D705CC199E4]
 
Péritonite infectieuse en dialyse péritonéale: une complication trop redoutée [Infectious peritonitis in peritoneal dialysis: an over-emphasized complication].
Vakilzadeh N., Burnier M., Halabi G., 2013. Revue Médicale Suisse, 9 (375) pp. 446-450.
[Pmid][serval:BIB_A1A3E9F1BC32]
 
Rein et tabac : revue de la littérature et mise au point [Kidney and smoking: literature review and focus].
Phan O., El Housseini Y., Burnier M., Vogt B., 2013. Néphrologie and Thérapeutique, 9 (2) pp. 67-72.
[DOI][WoS][Pmid][serval:BIB_7D329674A757]
 
Renal protection with calcium antagonists: the role of lercanidipine.
Burnier M., 2013. Current Medical Research and Opinion, 29 (12) pp. 1727-1735.
[DOI][WoS][Pmid][serval:BIB_1F9CA1ED8A2E]
 
Renal tissue oxygenation in essential hypertension and chronic kidney disease.
Pruijm M., Hofmann L., Vogt B., Muller M.E., Piskunowicz M., Stuber M., Burnier M., 2013. International Journal of Hypertension, 2013 (696598) p. 696598.
[DOI][Pmid][serval:BIB_7D94C32E9023]
 
Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension.
Ronzaud C., Loffing-Cueni D., Hausel P., Debonneville A., Malsure S.R., Fowler-Jaeger N., Boase N.A., Perrier R., Maillard M., Yang B. et al., 2013. Journal of Clinical Investigation, 123 (2) pp. 657-665.
[URN][DOI][WoS][Pmid][serval:BIB_218B3682F156]
 
Residual effect of renal denervation in patients with truly resistant hypertension.
Persu A., Azizi M., Burnier M., Staessen J.A., 2013. Hypertension, 62 (3) pp. 450-452.
[DOI][WoS][Pmid][serval:BIB_398702463878]
Response to "assessment of blood pressure dipping: is the evaluation method important?".
Wuerzner G., Burnier M., 2013. American Journal of Hypertension, 26 (8) p. 1054.
[URN][DOI][WoS][Pmid][serval:BIB_F93C26A98096]
Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial.
Forni V., Bianchi G., Ogna A., Salvadé I., Vuistiner P., Burnier M., Gabutti L., 2013. BMC Nephrology, 14 (157) pp. 1-10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BFEA80800218]
Severe hypercalcemia after a single high dose of vitamin D in a patient with sarcoidosis.
Hassler A., Lamy O., Rossier A., Sartori C., Gachoud D., 2013. Rheumatology International, 33 (11) pp. 2955-2956.
[URN][DOI][WoS][Pmid][serval:BIB_AA2467EA35D1]
Step count is associated with lower nighttime systolic blood pressure and increased dipping.
Wuerzner G., Bochud M., Zweiacker C., Tremblay S., Pruijm M., Burnier M., 2013. American Journal of Hypertension, 26 (4) pp. 527-534.
[URN][DOI][WoS][Pmid][serval:BIB_742A598070BD]
 
Stimulated sweating as a therapy to reduce interdialytic weight gain and improve potassium balance in chronic hemodialysis patients: a pilot study.
Pruijm M., El-Housseini Y., Mahfoudh H., Jarraya F., Hachicha J., Teta D., Burnier M., 2013. Hemodialysis International., 17 (2) pp. 240-248.
[DOI][WoS][Pmid][serval:BIB_5A9573BEE163]
 
Traitement de l'hypertension artérielle chez le sujet obèse [Treatment of hypertension in obese patients].
Comte-Perret S., Giusti V., Wuerzner G., 2013. Revue Médicale Suisse, 9 (397) pp. 1622-1626.
[Pmid][serval:BIB_3FE9878B136C]
 
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.
Schmidtko J., Peine S., El-Housseini Y., Pascual M., Meier P., 2013. American Journal of Kidney Diseases, 61 (2) pp. 289-299. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1C5156F18BCC]
 
Treatment of Resistant Hypertension. Which Additional Antihypertensive Drugs?
Burnier M., Pechère Bertschi A., Wuerzner G., 2013. pp. 115-126 dans Mancia G. (eds.) Resistant Hypertension : Epidemiology, Pathophysiology, Diagnosis and Treatment, Springer.
[DOI][serval:BIB_0295D71CC12B]
α-Ketoglutarate regulates acid-base balance through an intrarenal paracrine mechanism.
Tokonami N., Morla L., Centeno G., Mordasini D., Ramakrishnan S.K., Nikolaeva S., Wagner C.A., Bonny O., Houillier P., Doucet A. et al., 2013. Journal of Clinical Investigation, 123 (7) pp. 3166-3171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_93F2D96819D4]
2012
Estimation of glomerular filtration rate in hospitalised patients: are we overestimating renal function?
Frank M., Guarino-Gubler S., Burnier M., Maillard M., Keller F., Gabutti L., 2012/12/19. Swiss medical weekly, 142 pp. w13708. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22A5E24403C6]
 
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Parving H.H., Brenner B.M., McMurray J.J., de Zeeuw D., Haffner S.M., Solomon S.D., Chaturvedi N., Persson F., Desai A.S., Nicolaides M. et al., 2012/12. New England Journal of Medicine, 367 (23) pp. 2204-2213. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA678180CBF9]
 
High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
Pruijm M., Schmidtko J., Aho A., Pagano S., Roux-Lombard P., Teta D., Burnier M., Vuilleumier N., 2012/12. Therapeutic Apheresis and Dialysis, 16 (6) pp. 588-594. Peer-reviewed.
[DOI][Pmid][serval:BIB_4FE19EA9B0E6]
 
Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy
Fakhouri F., Vercel C., Fremeaux-Bacchi V., 2012/12. Clin J Am Soc Nephrol, 7 (12) pp. 2100-6.
[DOI][Pmid][serval:BIB_41D945BCB50D]
 
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
Zuber J., Fakhouri F., Roumenina L. T., Loirat C., Fremeaux-Bacchi V., French Study Group for a Hus C. G., 2012/11. Nat Rev Nephrol, 8 (11) pp. 643-57.
[DOI][Pmid][serval:BIB_6B2B665F8EC9]
Vitamin D levels and associated factors: a population-based study in Switzerland.
Guessous I., Dudler V., Glatz N., Theler J.M., Zoller O., Paccaud F., Burnier M., Bochud M., Swiss Survey on Salt Group, 2012/11. Swiss Medical Weekly, 142 p. 0.
[URN][DOI][WoS][Pmid][serval:BIB_6364F33C5A95]
 
Améliorer la prise en charge de l'hypertension arterielle en favorisant la collaboration avec les pharmaciens et les infirmières [Team-based care involving pharmacists and nurses to improve the management of hypertension].
Santschi V., Wuerzner G., Chiolero A., Burnand B., Paradis G., Burnier M., 2012/09. Revue médicale suisse, 8 (353) pp. 1694-6, 1698.
[Pmid][serval:BIB_518B665EC473]
 
Réduction de la consommation de sel: opportunité, impact et stratégies. [Population reduction of salt consumption: opportunities, impact and strategies].
Bochud M., Marques-Vidal P., Burnier M., Paccaud F., 2012/07. Revue médicale suisse, 8 (348) pp. 1443-1447.
[Pmid][serval:BIB_65C8A0D0B6CD]
 
Hypertoniebehandlung bei Nierenarterienstenose [Hypertension therapy in patients with renal artery stenosis].
Vogt B., Maillard M., Burnier M., 2012/05. Therapeutische Umschau. Revue Thérapeutique, 69 (5) pp. 279-281.
[DOI][Pmid][serval:BIB_E5DF3D4282AE]
 
Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study
Chapal M., Debout A., Dufay A., Salomon R., Roussey G., Burtey S., Launay E. A., Vigneau C., Blancho G., Loirat C. et al., 2012/05. Nephrol Dial Transplant, 27 (5) pp. 2083-8.
[DOI][Pmid][serval:BIB_36B98DA3253C]
 
Blocage du système rénine-angiotensine: il ne faut pas abuser des bonnes choses [Renin angiotensin system inhibitors: too much of a good thing can be dangerous].
Burnier M., Martin P.Y., 2012/02. Revue Médicale Suisse, 8 (330) pp. 443-444.
[Pmid][serval:BIB_AA0D608E5520]
Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome.
Barzaghi F., Passerini L., Gambineri E., Ciullini Mannurita S., Cornu T., Kang E.S., Choe Y.H., Cancrini C., Corrente S., Ciccocioppo R. et al., 2012/02. Journal of autoimmunity, 38 (1) pp. 49-58. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3A2537950A25]
 
Hyponatremia and mortality in patients with cancer: the devil is in the details
Fakhouri F., Lavainne F., Karras A., 2012/02. Am J Kidney Dis, 59 (2) pp. 168-9.
[DOI][Pmid][serval:BIB_0D76025EF501]
 
Target blood pressure attainment with antihypertensive therapy in Swiss primary care.
Hendrik Schäfer H., Sudano I., Theus G.R., Noll G., Burnier M., 2012/02. Blood Pressure, 21 (4) pp. 211-219.
[DOI][WoS][Pmid][serval:BIB_93D3C9B0AEE3]
 
A randomized controlled trial to assess effectiveness of polypill in primary health care in Seychelles
Bovet P., Gedeon J., Burnier M., Paccaud F., 2012. dans Global Summit on Combination Polypharmacy for Cardiovascular Disease.
[serval:BIB_FFE521CD4029]
 
Adipokines as uremic toxins.
Teta D., 2012. Journal of Renal Nutrition, 22 (1) pp. 81-85.
[DOI][WoS][Pmid][serval:BIB_B45702195AAD]
 
Amyloïdose rénale [Renal amyloidosis].
Cuchard P., Cuchard R., Rotman S., Burnier M., Gauthier T., 2012. Revue Médicale Suisse, 8 (330) pp. 446-451.
[Pmid][serval:BIB_A04BBD2F5090]
Antidiabetic drugs and kidney disease - Recommendations of the Swiss Society for Endocrinology and Diabetology.
Zanchi A., Lehmann R., Philippe J., 2012. Swiss Medical Weekly, 142 pp. w13629.
[URN][DOI][WoS][Pmid][serval:BIB_0B982F37FE27]
 
Antihypertensive therapies
Wuerzner G., Muller O., Burnier M., 2012. pp. 78-88 dans White H.D. (eds.) Advances in Acute Coronary Syndrome Management, Future Medicine.
[DOI][serval:BIB_E06B67E80062]
 
Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography.
Dunet V., Qanadli S.D., Allenbach G., Dabiri A., Mazzolai L., Waeber B., Feihl F., Prior J.O., 2012. Circulation journal : official journal of the Japanese Circulation Society, 76 (1) pp. 160-167. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B936E95E0BA]
 
Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!
Waeber B., 2012. Journal of the Renin-angiotensin-aldosterone System, 13 (1) pp. 216-219. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_325500BBCB54]
 
Blood pressure in hospitalized patients: should we still measure it?
Burnier M., 2012. Journal of Hypertension, 30 (10) pp. 1913-1914. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33E57CFE1226]
Blood pressure target attainment in the background of guidelines: the very elderly in Swiss primary care.
Schäfer H.H., Sudano I., Theus G.R., Zilla P., Noll G., Burnier M., 2012. Family Practice, 29 (5) pp. 511-520.
[URN][DOI][WoS][Pmid][serval:BIB_610628896544]
 
Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension.
Guessous I., Dobrinas M., Kutalik Z., Pruijm M., Ehret G., Maillard M., Bergmann S., Beckmann J.S., Cusi D., Rizzi F. et al., 2012. Human Molecular Genetics, 21 (14) pp. 3283-3292. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1D2BE11940C7]
 
Différences induites par la définition des périodes diurnes et nocturnes sur la pression artérielle et le dipping lors d'une mesure ambulatoire de la pression artérielle [Effects of nighttime and daytime interval definition on blood pressure and dipping in patients referred for ambulatory blood pressure measurement].
Muller M.E., Bochud M., Pruijm M., Iglesias K., Burnier M., Wuerzner G., 2012. Annales de Cardiologie et d'Angéiologie, 61 (3) pp. 193-197. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F3AE32114BF1]
 
Dénervation rénale pour le traitement de l'hypertension artérielle résistante: proposition pour une attitude multidisciplinaire commune [Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude].
Muller O., Qanadli S.D., Waeber B., Wuerzner G., 2012. Revue Médicale Suisse, 8 (343) pp. 1159-1163.
[Pmid][serval:BIB_D30B1C161C7A]
 
Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis
Le Roux S., Pepper R. J., Dufay A., Neel M., Meffray E., Lamande N., Rimbert M., Josien R., Hamidou M., Hourmant M. et al., 2012/01. J Am Soc Nephrol, 23 (1) pp. 155-64.
[DOI][Pmid][serval:BIB_86B7B0D2F5BD]
Endothelin receptor antagonists: a place in the management of essential hypertension?
Burnier M., Forni V., 2012. Nephrology, Dialysis, Transplantation, 27 (3) pp. 865-868.
[URN][DOI][WoS][Pmid][serval:BIB_7A1B116930A5]
 
Estimation of salt intake using 24-hour urine collection: Switzerland
Chappuis A., Paccaud F., Bochud M., Burnier M., 2012. dans Geneva Health Forum 2012, A Critical Shift to Chronic Conditions: Learning from the Frontliners.
[serval:BIB_DEE791CB66F1]
 
Evolving trends in hypertension therapy: focus on olmesartan-based therapies
Michel Burnier, Grégoire Wuerzner, 2012. Hot Topics in Hypertension.
[DOI][serval:BIB_EA33ABF62849]
 
Genetik der essentiellen arteriellen Hypertonie [Essential hypertension - which genes can be held responsible for it?].
Ackermann D., Ponte B., Pruijm M., 2012. Therapeutische Umschau. Revue Thérapeutique, 69 (5) pp. 273-278.
[DOI][Pmid][serval:BIB_62332C4B565E]
Genome-wide association study to identify common variants associated with brachial circumference: a meta-analysis of 14 cohorts.
Boraska V., Day-Williams A., Franklin C.S., Elliott K.S., Panoutsopoulou K., Tachmazidou I., Albrecht E., Bandinelli S., Beilin L.J., Bochud M. et al., 2012. Plos One, 7 (3) pp. e31369 [10 p.]. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8B56012693D2]
 
Hypertension artérielle: une page se tourne!
Waeber B., Burnier M., Pechère Bertschi A., 2012. Revue Médicale Suisse, 8 (353) pp. 1691-1692.
[Pmid][serval:BIB_A6F0B091CC0F]
 
Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.
Wang Q., Domenighetti A.A., Schäfer S.C., Weber J., Simon A., Maillard M.P., Pedrazzini T., Chen J., Lehr H.A., Burnier M., 2012. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 302 (9) pp. R1025-R1033.
[DOI][Pmid][serval:BIB_5B4B77092495]
Incidence, complications and risk factors for severe falls in patients on maintenance haemodialysis.
Rossier A., Pruijm M., Hannane D., Burnier M., Teta D., 2012. Nephrology, Dialysis, Transplantation, 27 (1) pp. 352-357.
[URN][DOI][WoS][Pmid][serval:BIB_C2807B2CAE7C]
 
Inducible kidney-specific Sgk1 knockout mice show a salt-losing phenotype.
Faresse N., Lagnaz D., Debonneville A., Ismailji A., Maillard M., Fejes-Toth G., Náray-Fejes-Tóth A., Staub O., 2012. American Journal of Physiology. Renal Physiology, 302 (8) pp. F977-F985.
[DOI][WoS][Pmid][serval:BIB_7ADEF5A6D2A0]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University